Applied Therapeutics has previously said it hoped to be able to file for accelerated FDA approval based on biomarker data showing that AT-007 was able to reduce levels of galactitol, the main ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its ...

Shares in Applied Therapeutics have lost more than 80% of their value after the FDA turned down its marketing application for lead drug govorestat as a treatment for galactosaemia. The sell-off ...

February 14, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and ...

The Applied Therapeutics class action lawsuit further alleges that on November 27, 2024, defendants revealed that the FDA issued a Complete Response Letter for the NDA for govorestat which ...

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want ...

Applied Therapeutics (APLT) (ISIN: US03828A1016)股票专题，提供今日Applied Therapeutics(APLT) (ISIN: US03828A1016)股票最新股价查询，实时市场行情，走势图表，及Applied Therapeutics Inc(APLT) (ISIN: ...

On November 27, 2024, Applied Therapeutics issued a press release stating that the FDA issued a Complete Response Letter for the NDA for govorestat. The Complete Response Letter stated that the ...